A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

NCT00663286 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1399

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: IDP-110
DRUG: Clindamycin
DRUG: Benzoyl peroxide
DRUG: Vehicle

Sponsor

Dow Pharmaceutical Sciences